🇪🇺 Cayston® in European Union

EMA authorised Cayston® on 21 September 2009

Marketing authorisation

EMA — authorised 21 September 2009

  • Application: EMEA/H/C/000996
  • Marketing authorisation holder: Gilead Sciences Ireland UC
  • Local brand name: Cayston
  • Indication: Cayston is indicated for the suppressive therapy of chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic fibrosis (CF) aged 6 years and older. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
  • Status: approved

Read official source →

Frequently asked questions

Is Cayston® approved in European Union?

Yes. EMA authorised it on 21 September 2009.

Who is the marketing authorisation holder for Cayston® in European Union?

Gilead Sciences Ireland UC holds the EU marketing authorisation.